Spiolto

Spiolto is a brand name for a combination medication used to treat chronic obstructive pulmonary disease (COPD). The active ingredients in Spiolto are tiotropium bromide and olodaterol. Tiotropium bromide is a long-acting anticholinergic agent, and olodaterol is a long-acting beta-agonist (LABA). These medications work together to help relax and widen the airways in the lungs, making it easier to breathe. Spiolto is administered as a dry powder inhaler, typically once daily.

COPD is a progressive lung disease that makes breathing difficult. It includes conditions such as emphysema and chronic bronchitis. Symptoms of COPD can include shortness of breath, coughing, and mucus production. Spiolto is prescribed to help manage these symptoms and reduce the frequency of exacerbations, which are periods when COPD symptoms worsen. It is important to use Spiolto as directed by a healthcare professional. Side effects can occur and may include dry mouth, constipation, and urinary tract infections. Patients should discuss any concerns or potential side effects with their doctor. Spiolto is not intended for use as a rescue inhaler for sudden breathing problems.